Targeting ELF3 with Biomimetic Nanotherapy Sensitizes PDAC to Gemcitabine via GSDME-mediated Pyroptosis.
Pancreatic ductal adenocarcinoma (PDAC) continues to be a lethal malignancy with limited effective treatment strategies due to modest intrinsic response to systemic chemotherapy. Moreover, the dense, fibrotic stroma and poor vasculature of pancreatic tumors severely restrict drug penetration and therapeutic efficacy. T...